Cambridge Investment Research Advisors’s Calamos S&P 500 Structured Alt Protection ETF - May CPSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.35M Buy
+46,915
New +$1.35M ﹤0.01% 1914
2025
Q1
Sell
-79,287
Closed -$2.12M 3658
2024
Q4
$2.12M Sell
79,287
-10,131
-11% -$269K 0.01% 1318
2024
Q3
$2.36M Sell
89,418
-311,733
-78% -$8.11M 0.01% 1223
2024
Q2
$10.3M Buy
+401,151
New +$10.2M 0.04% 450

Other funds holding CPSM

Cambridge Investment Research Advisors's CPSM Position: Q1 2026 in Review

Cambridge Investment Research Advisors opened a new position in Calamos S&P 500 Structured Alt Protection ETF - May (CPSM) in Q1 2026: 46,915 shares worth $1.35M. The stake represents ﹤0.01% of the portfolio and ranks #1914 among its holdings. This is a return to the name: Cambridge Investment Research Advisors previously reported a position in CPSM as recently as Q4 2024.

Cambridge Investment Research Advisors first reported a position in CPSM in Q2 2024 and has held it in 4 quarters since. The position peaked at $10.3M in Q2 2024. 26 funds tracked by Wall St. Rank hold CPSM as of Q1 2026.

  • Cambridge Investment Research Advisors held 46,915 shares of Calamos S&P 500 Structured Alt Protection ETF - May worth $1.35M as of Q1 2026.
  • Calamos S&P 500 Structured Alt Protection ETF - May was a new Cambridge Investment Research Advisors position in Q1 2026.
  • Calamos S&P 500 Structured Alt Protection ETF - May made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q1 2026, its #1914 holding.
  • Cambridge Investment Research Advisors first reported a position in Calamos S&P 500 Structured Alt Protection ETF - May in Q2 2024 and has held it in 4 quarters since.
  • Cambridge Investment Research Advisors's Calamos S&P 500 Structured Alt Protection ETF - May position peaked at $10.3M in Q2 2024.
  • 26 funds tracked by Wall St. Rank held Calamos S&P 500 Structured Alt Protection ETF - May as of Q1 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.